Coronavirus - we're here to help
From how to access your account online, scam awareness, your wellbeing and our community we're here to help.

Skip to main content
  • Register
  • Help
  • Contact us
  • Log in to HL Account

Midatech Pharma plc (MTPH) ORD GBP0.001

Sell:32.00p Buy:34.00p 0 Change: 0.50p (1.49%)
Market closed Prices as at close on 12 August 2020 Prices delayed by at least 15 minutes | Switch to live prices |
Sell:32.00p
Buy:34.00p
Change: 0.50p (1.49%)
Market closed Prices as at close on 12 August 2020 Prices delayed by at least 15 minutes | Switch to live prices |
Sell:32.00p
Buy:34.00p
Change: 0.50p (1.49%)
Market closed Prices as at close on 12 August 2020 Prices delayed by at least 15 minutes | Switch to live prices |
The selling price currently displayed is higher than the buying price. This can occur temporarily for a variety of reasons; shortly before the market opens, after the market closes or because of extraordinary price volatility during the trading day.

Business summary

Midatech Pharma PLC is a research and development biopharmaceutical company that is focused on commercializing and developing products in oncology and other therapeutic areas. The Company operates through Pipeline Research and Development segment. The Pipeline Research and Development segment seeks to develop products using the nanomedicine and sustained release technology platforms. The Company develops chemo therapeutics or new immune therapeutics, using its drug delivery technologies. Q-Sphera platform is the polymer microsphere technology is used for sustained release at the microscale to prolong and control the release of therapeutics over an extended period of time from weeks to months. Midasolve platform is its nanosaccharide technology is used to dissolve drugs at the nanoscale so that they can be administered in liquid form directly and locally into tumours. Midacore platform is the gold nanoparticle technology that is used for targeting sites of disease at the nanoscale.

Contact details

Address:
Oddfellows Hse, 19 Newport Road
ABINGDON
CF24 0AA
United Kingdom
Telephone:
+44 (01235) 841575
Website:
www.midatechpharma.com/

Important dates

Future events
There are no future events available.
Past events
AGM 31 July 2020 31/07/20
Annual report 30 June 2020 30/06/20
Final results 16 June 2020 16/06/20
Final results 18 May 2020 18/05/20
General meeting 02 March 2020 02/03/20
Interim results 30 September 2019 30/09/19

General stock information

EPIC:
MTPH
ISIN:
GB00BKT14T00
Market cap:
£19.98 million
Shares in issue:
60.55 million
Sector:
Pharmaceuticals & Biotechnology
Exchange:
London Stock Exchange
Currency:
Sterling pence
Indices:
n/a

Key personnel

  • Stephen Stamp
    Chief Executive Officer, Chief Financial Officer, Director
  • Daniel Palmer
    Chief Scientific Officer
  • Justin Barry
    Head - Manufacturing
  • Tim Sparey
    Chief Business Officer

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Business summary, contact details and key personnel provided by Thomson Reuters. Important dates provided by Digital Look Ltd. General stock information provided by NBTrader.

Share

The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.

Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.